Paradigm Capital assumed coverage on shares of OrganiGram (OTCMKTS:OGRMF) in a research note published on Wednesday, April 17th, TipRanks reports. The firm issued a buy rating on the stock.
Separately, Jefferies Financial Group began coverage on shares of OrganiGram in a report on Monday, February 25th. They issued a buy rating for the company.
OTCMKTS:OGRMF traded up $0.09 during trading hours on Wednesday, hitting $6.82. 327,222 shares of the stock traded hands, compared to its average volume of 869,327. OrganiGram has a fifty-two week low of $2.97 and a fifty-two week high of $7.72.
OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.
Featured Story: Dollar Cost Averaging
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.